The 8-Week Efficacy of Frequency Rhythmic Electrical Modulated System (FREMS) as an Add-on Therapy in the Treatment of Symptomatic Diabetic Peripheral Polyneuropathy.
| Autor: | Gorczyca-Siudak D; Faculty of Human Sciences, University of Economics and Innovation, St. 4 Projektowa, 20-209 Lublin, Poland., Dziemidok P; Faculty of Human Sciences, University of Economics and Innovation, St. 4 Projektowa, 20-209 Lublin, Poland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Dec 22; Vol. 20 (1). Date of Electronic Publication: 2022 Dec 22. |
| DOI: | 10.3390/ijerph20010111 |
| Abstrakt: | Background: Frequency Rhythmic Electrical Modulated System (FREMS) is a method of transcutaneous treatment based on frequency-modulated electromagnetic neural stimulation. Its efficacy in neuropathic pain in diabetes mellitus still lacks enough research. Methods: A randomized, single-blind, sham-controlled trial in individuals with symmetric distal polyneuropathy (SDPN) as an add-on therapy compared to standard therapy with alpha-lipoic acid. Participants were randomized to FREMS and standard of care (SOC) versus SOC only. The primary outcome was a change from baseline in perceived pain assessed by visual analogue scale (VAS) after 5 days of treatment and after 8 weeks of follow-up between treatment groups. Results: After 5 days of treatment, patients in both groups felt significant reduction in pain as measured by VAS, although only FREMS treatment lasted for 8 weeks and induced a significant improvement in quality of life measured by EuroQol 5-Dimension 5-Level (EQ-5D-5L) and Clinical Global Impression of Change (CGI-C) questionnaires. There were non-significant differences observed in the instrument pain assessment. No relevant side effects were recorded during the study. Conclusions: FREMS as an addition to alpha-lipoic acid therapy occurred to be a beneficial method of treatment in individuals with SDPN and was associated with improvements in pain severity, quality of life and clinical global improvement. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|